Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.

Annals of surgical oncology - 1 Feb 2014

Jin Yan, Sun Ping-Li, Kim Hyojin, Seo An Na, Jheon Sanghoon, Lee Choon-Taek, Chung Jin-Haeng

Abstract excerpt

BACKGROUND: MET gene copy number gain (CNG) and protein overexpression have been reported in lung cancer, but the clinical implications in early stage adenocarcinoma remain unclear. METHODS: We investigated MET gene copy number and protein expression in 141 cases of surgically resected stage I pulmonary adenocarcinoma. MET gene CNG was determined by silver in situ hybridization, and MET protein expression was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to Gene Rearrangement

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoenzyme Techniques

Share to Neoplasm Invasiveness

Share to Proto-Oncogene Proteins c-met

Share to Receptor Protein-Tyrosine Kinases

Share to Silver

Share to Tissue Array Analysis

Source

Identifiers

PMID: 24212721
DOI: 10.1245/s10434-013-3355-1

Genes

MET
ALK
EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.PMID 24212721Read ↗

Increased <i>MET</i> Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer PatientsSemantic proximity Read ↗

MET Gene Amplification and Overexpression in Chinese Non-Small-Cell Lung Cancer Patients Without EGFR Mutations.Semantic proximity Read ↗

Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer.Semantic proximity Read ↗

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung AdenocarcinomaSemantic proximity Read ↗

Phase II, open-label, multicenter trial of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study.Semantic proximity Read ↗

High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.Semantic proximity Read ↗

ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations.Semantic proximity Read ↗

Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosisSemantic proximity Read ↗

MET overexpression and gene amplification: prevalence, clinico-pathological characteristics and prognostic significance in a large cohort of patients with surgically resected NSCLCSemantic proximity Read ↗

Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancerSemantic proximity Read ↗

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)Semantic proximity Read ↗

Clinicopathological characteristics of Non-Small Cell Lung Cancer (NSCLC) patients with c-MET exon 14 skipping mutation, MET overexpression and amplification.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.